key: cord-0754390-9y1y28d3 authors: Espinoza-Derout, Jorge; Shao, Xuesi M.; Lao, Candice J.; Hasan, Kamrul M.; Rivera, Juan Carlos; Jordan, Maria C.; Echeverria, Valentina; Roos, Kenneth P.; Sinha-Hikim, Amiya P.; Friedman, Theodore C. title: Electronic Cigarette Use and the Risk of Cardiovascular Diseases date: 2022-04-07 journal: Front Cardiovasc Med DOI: 10.3389/fcvm.2022.879726 sha: 512876bf0a20ad52b1fbcfd567a29e699abd8bfe doc_id: 754390 cord_uid: 9y1y28d3 Electronic cigarettes or e-cigarettes are the most frequently used tobacco product among adolescents. Despite the widespread use of e-cigarettes and the known detrimental cardiac consequences of nicotine, the effects of e-cigarettes on the cardiovascular system are not well-known. Several in vitro and in vivo studies delineating the mechanisms of the impact of e-cigarettes on the cardiovascular system have been published. These include mechanisms associated with nicotine or other components of the aerosol or thermal degradation products of e-cigarettes. The increased hyperlipidemia, sympathetic dominance, endothelial dysfunction, DNA damage, and macrophage activation are prominent effects of e-cigarettes. Additionally, oxidative stress and inflammation are unifying mechanisms at many levels of the cardiovascular impairment induced by e-cigarette exposure. This review outlines the contribution of e-cigarettes in the development of cardiovascular diseases and their molecular underpinnings. Tobacco consumption has been present in the Americas since prehistoric times (1) . After tobacco was introduced from indigenous inhabitants of the Western hemisphere to Europeans through members of Columbus' crew (1) , the effects of tobacco use have been a subject of scientific controversy. In the 16th century, the Spaniard physician and botanist Nicolás Monardes published a book explaining the therapeutic effects of tobacco use for dozens of health problems (2) . Although in the 17th century, King James I of England spoke about the dangerous effects of tobacco (3), the systematic observations of the negative health effects of tobacco took longer than expected. In the first part of the 20th century, pathologists observed a strong association between lung cancer and cigarette smoking (4) . The rate of smoking peaked in the 60s, with about 42% of the adult population in the United States being tobacco smokers in 1965 (5) . By 2019, however, the smoking rate among adults aged 18 years or older went down to 14.0% (6) . Currently, cigarette smoking is still the leading cause of preventable death, contributing to chronic obstructive pulmonary disease, several types of cancer, diabetes, and cardiovascular disease (CVD) (7) , and is an additive risk factor in COVID-19 (8) . Although the use of cigarettes has decreased in the last few years, addiction to nicotine has continued due to the introduction of electronic cigarettes or e-cigarettes to the market. In 2004, a Beijing-based company, Ruyan Group (Holdings) Ltd., China, patented and launched e-cigarettes (9) that delivered nicotine to users without burning tobacco (10) . E-cigarettes are battery-powered devices that produce an aerosol generated by heating a solution (e-liquid) consisting of nicotine, glycerol, propylene glycol, and flavors. The first generation of ecigarettes tried to mimic the experience of smoking conventional cigarettes. The later generation devices contain high-powered atomizers and use higher nicotine concentrations in the eliquids, increasing the speed of delivery and yield of nicotine like conventional cigarettes (11) . JUUL and other pod-mods use nicotine formulations derived from the nicotine salts in looseleaf tobacco (12, 13) . Nicotine salts in pod-mods such as JUUL reduce harshness and result in a satisfying experience even at high nicotine concentrations (14) . Although e-cigarettes were initially marketed as a smoking cessation tool, they will likely lead to future conventional cigarette smoking in people that have never smoke (15, 16) . Especially concerning is the effect of ecigarettes on the youth, and it is noteworthy that 19.6% of high school students used e-cigarettes in 2020 (17) . Smokers who use e-cigarettes in an attempt to stop smoking often end up using both products. These dual users have been found to have higher cardiovascular risk factors than single users (18) . Smoking is associated with 11% of cardiovascular deaths worldwide (19) . Currently, heart disease is the leading cause of death in the United States. Atherosclerosis is a chronic inflammatory condition associated with the accumulation of lipids and fibrous elements in the arteries where inflammatory cells are recruited to the arterial walls. The effects of conventional cigarettes on the cardiovascular system have been extensively studied (20, 21) . Although e-cigarettes have the potential to be less harmful than conventional cigarettes due to their reduced number of harmful chemicals, the precise toxicological and mechanistic data of the effects e-cigarettes have on the cardiovascular system remain to be elucidated. A cross-sectional analysis of cardiovascular symptoms showed that e-cigarette users have a higher risk of coronary heart disease, arrhythmia, chest pain, or palpitations (22) . One of the complexities of studying the cardiovascular effects of e-cigarettes is the large variety of devices and chemical compositions of e-liquids. Different e-cigarettes' devices may produce different chemical products by thermal degradation of e-cigarette liquids and differences in the size of fine particulate matter (PM 2.5 ) or ultrafine particles (UFPs). The negative effects of PM 2.5 and UFPs on the cardiovascular system are wellestablished (23, 24) . In indoor studies, e-cigarettes produce PM 2.5 and UFPs concentrations ∼45 and 20 times higher, respectively, than recommended by the World Health Organization (25) . Additionally, the heating temperature in e-cigarettes creates metal particles (copper, nickel, and silver) from the atomizer unit (26) that are delivered into the bloodstream through the lungs. The literature on the consequences of second-hand e-cigarette vaping is limited. However, chemical components are partially exhaled by users of electronic cigarettes. Consequently, it is important to study the effect of second-hand e-cigarette aerosol on CVD (27) . Furthermore, exhaled nicotine and other eliquid components can deposit onto surfaces and subsequently negatively affect the health of those exposed (third-hand exposure). In addition, toxicological studies of the components of e-cigarettes such as glycerol, propylene glycol, and artificial flavors have been mainly tested via oral administration, but very few studies have investigated the effect of aerosolizing the content of e-cigarettes at a high temperature. It is also widely known that E-liquid thermal decomposition produces the breakdown of glycerol and propylene glycol into toxic aldehydes, acetaldehyde, acrolein, and formaldehyde (28, 29) . Acrolein produces lipid peroxidation and modifies the component of high-density lipoprotein (HDL) Apolipoprorein-I (ApoA-I). This fact leads to speculation on the role of chronic e-cigarette consumption in the development of atherosclerosis (30) . Additionally, acrolein produces vascular oxidative stress (31) and platelet activation, a risk factor for thrombotic vascular events (32) . Fortunately, the concentrations of acrolein produced by e-cigarettes are likely to be too low to have effects of clinical relevance (33) . Given that the concentration of the carbonyl compounds positively correlates with the voltage and temperature of e-cigarettes (34) , tight monitoring of the acrolein production from e-cigarettes may be necessary. Increasing the complexity of the toxicological analysis of e-cigarettes is the existence of more than 7,000 flavors for e-liquids in the market (35) . Most of these thousands of flavors have been tested for oral ingestion safety; however, there is no complete data on their safety of the exposure to these components once heated and inhaled. For instance, experimental evidence shows that vanillin, cinnamaldehyde, eugenol, and acetylpyridine flavors induce nitric oxide and proinflammatory interleukins in endothelial cells (36) , and vanilla custard e-vapor extract increased necrotic and apoptotic HL-1 cardiomyocyte cells (37) . Adding to this complexity, e-cigarette users modify devices and solutions, which may further impact the toxicological characteristic of e-cigarettes (38) . Figure 1 summarizes the proposed mechanisms of e-cigarettes' effects on the cardiovascular system. Nicotine is the most studied biologically active chemical present in e-cigarettes, and several of the cardiovascular effects of ecigarettes have been attributed to this alkaloid from the tobacco plant (39) . Nicotine is a highly addictive drug, having wellestablished effects on the metabolism (40-42) and cardiovascular system (7, 39, 43) . Higher levels of nicotine in e-cigarettes have been associated with an increase in the frequency and intensity of combustible cigarette smoking (44). The acute and chronic effects of nicotine differ as chronic exposure induces fast desensitization of the nicotine receptors. For instance, although nicotine in e-cigarettes can acutely increase blood pressure, chronic smoking has not been linked to higher blood pressure in most epidemiological studies (45). Nicotine has systemic hemodynamic effects that are mediated by the activation of the sympathetic nervous system. Thus, acute nicotine treatment can stimulate cardiac output by producing systemic vasoconstriction and increasing heart rate (45). Nicotine activates macrophages which infiltrate atherosclerotic lesions and release cytokines such as the TNF-1β and IL-1β that increase inflammation (46). The most common complication of atherosclerosis is the formation of a thrombus that leads to a stroke or a myocardial infarction. Nicotine has thrombogenic activity by activating platelets and coagulation cascades (20) . Nicotine binds to the nicotinic acetylcholine receptors (nAChRs), which are integral membrane proteins that belong to the ligandgated ion channel superfamily (47). Several nAChRs subunit combinations can form great diversity of functional receptors with a variety of specialized functions and properties depending on the cell type (48). Although the roles of nAChRs in synaptic transmission in the central (CNS) and peripheral nervous systems (PNS) are the most studied, nAChRs are present in several non-neuronal cells (49). In the cardiovascular system, vascular endothelial cells and smooth muscle cells (VSMC) express several subunits of nAChRs (50, 51). The activation of endothelial cells can lead to the release of vasoconstrictor substances. For instance, nicotine increases the release of endothelin-1 from human umbilical vein endothelial cells (52). Carotid arteries treated with nicotine show an impairment of endothelial-dependent relaxation associated with a decreased eNOS expression (53). In aortic smooth muscle cells, nicotine enhances insulin-induced mitogenesis through up-regulation of α7nAChR, a phenomenon associated with atherosclerosis (54) . Additionally, nicotine has pro-angiogenic effects through the activation of α7nAChR (55) . Nicotine produces arterial stiffness through extracellular matrix remodeling by upregulating matrix metalloproteinases (56) . In the right ventricle, nicotine treatment lead to α7nAChR activation and fibroblast proliferation, collagen production, and extracellular matrix remodeling (57) . Therefore, genetic or pharmacological inhibition of the α7nAChR rescues the effects of nicotine on right ventricular fibrosis (57) . pH and Nicotine E-cigarettes are formulated to have different pH levels, perhaps designed to increase their sensory impact (58) . Traditional ecigarette products use e-liquid with free-base nicotine while a new generation of e-cigarettes, the pod-mods, such as JUUL, use nicotine salts (12) . The pH of the E-liquid is a function of the concentration of the free-base nicotine and the concentration of the nicotine salt. If the E-liquid contains free-base nicotine, the pH is high. If the E-liquid contains nicotine salt, the pH can be lower as a range from 5 to 7 (12) . Previous studies have reported that the pH of e-liquids ranges from 8 to 10 for conventional e-cigarettes (59) and around 6 for JUUL (12, 60) . Regarding the health effects, two aspects of e-liquid pH are often discussed: (1) Different sensory experiences. High pH ecigarette aerosol appeared to be harsher, while lower pH close to physiological levels provides a more satisfying experience (13, 14) . Where pKa is the logarithmic acid dissociation constant. Protonated nicotine is the ligand of nAChR (61) . Theoretically, high protonated nicotine [NicH + ] in the e-cigarette aerosol can have a greater impact on cells expressing the nAChRs in the respiratory tract (12) . On the other hand, unprotonated nicotine [Nic] is lipophilic; thus, following inhalation, it would more readily diffuse across pulmonary cell membrane (12) . High [Nic] can induce a rapid rising phase and higher peak concentrations in the arterial blood, and as a consequence, greater cardiovascular effects, increasing the risk of cardiovascular events such as cardiac arrhythmia, fluctuations of blood pressure and disruption of hemodynamic processes (62) . Smoking is a risk factor for insulin resistance in a dosedependent manner (63) . Smokers have lower glucose uptake and are more insulin resistant compared to nonsmokers (64) . They also have higher plasma triglyceride (TG) and lower HDLcholesterol levels (64) . These findings on insulin resistance in smokers have been reproduced (65) (66) (67) (68) (69) (70) (71) and support other studies showing that insulin resistance can lead to both dyslipidemia (72) and endothelial dysfunction (73) seen in smokers. The degree of insulin resistance was also positively correlated to tobacco consumption (66) , and, in long-term users of nicotine gum, to serum cotinine levels. Cotinine is a metabolite from nicotine; serum or urine levels of cotinine are considered to reflect the degree of nicotine use (63, 74) . This implies nicotine as the causative agent of insulin resistance. In contrast to its effects on insulin sensitivity, cigarette smoking does not affect insulin secretion (64, 75, 76) . Even acute smoking (one cigarette) impaired insulin sensitivity in healthy young men (66) and impaired glucose tolerance and insulin sensitivity in both smokers and non-smokers (77) . Data from the Copenhagen male study indicated that only those smokers who have characteristic dyslipidemia associated with insulin resistance were at greatly increased CVD risk (78) . Accordingly, with the effect of nicotine, e-cigarette users have higher fasting glucose levels than never users (79) . In large-population-based studies, cigarette smoking was associated with an increased incidence of Type 2 diabetes mellitus (DM) (80) and metabolic syndrome [as defined by the National Cholesterol Education Program (81)]. A systematic meta-analysis confirmed the association between smoking and DM (82) , and an editorial suggested that 12% of DM in the US is attributable to smoking (83) . Cigarette smokers who were insulin sensitive did not display any abnormalities of lipoprotein metabolism (84) . In contrast, cigarette smokers who were also insulin resistant had significantly higher plasma concentrations of TG and VLDL-cholesterol. Insulin resistance predicts the development of age-related diseases, including hypertension, stroke, coronary artery disease, cancer, and type 2 DM (85). Thus, it can be argued that a defect leading to increased CVD risk in smokers is insulin resistance and that the multiple adverse consequences associated with insulin resistance, including dyslipidemia and endothelial dysfunction, are responsible for the accelerated atherogenesis in these individuals (86) . Atherosclerosis is a chronic inflammatory condition associated with the accumulation of lipids and fibrous elements in the arteries where inflammatory cells are recruited to the arterial walls. Increased production of reactive oxygen species (ROS) is a unifying mechanism for several risk factors that induce arteriosclerosis, endothelial cell dysfunction, and cardiac dysfunction (87-91). Increased ROS can produce activation of pro-apoptotic signaling resulting in cardiac remodeling and dysfunction (92) . Mitochondria are both a major source of ROS and the primary target of ROS damage (93) . Given that mitochondrial DNA (mtDNA) lacks protection from histones and has proximity to the source of ROS, it is very susceptible to oxidative alterations of nucleotides in the sequence of its coding regions (94) . Thus, mtDNA mutations can lead to mitochondrial dysfunction and inefficient energy production of cardiac cells (95) . Chronic ROS production results in the accumulation of mtDNA mutations, oxidized proteins, and lipids, leading to mitochondrial dysfunction and energy deficits in the heart (96) . E-cigarettes induce increased ROS in vitro and in vivo in endothelial cells (97) , which leads to DNA damage (97) , mt DNA mutations (39) , and lipid peroxidation, all of which indicate oxidative stress and ROS-mediated damage of cells. ROS can directly impair the nitric oxide (NO)-mediated vasorelaxation by quenching NO (98) . Exposure to e-cigarettes aerosols for 12 weeks induced an inflammatory phenotype consisting in high levels of lipid peroxidation and mitochondrial DNA mutations in a nicotine-dependent manner (39) . Recently, it has been reported an increase in both lipid peroxidation and inflammation induced by e-cigarettes were associated with heart fibrosis in rats (99) . The role of inflammation in the development of atherosclerosis (100) and heart failure (101) is well-established. Transcriptomic analysis of hearts exposed to e-cigarettes showed that mice exposed to e-cigarettes had dysregulation of signaling factors involved in inflammation, circadian rhythm regulation, and leukocyte extravasation (39) . In primary microvascular endothelial cells, e-cigarettes, and conventional cigarettes decreased the expression of the tight junctional protein Zonula Occludens-1 (ZO-1), suggesting that they alter the blood-brain barrier integrity (102) . This effect was also accompanied by the activation of Nuclear factor-erythroid factor 2-related factor 2 (Nrf2), a main cellular transcription factor of the oxidative stress response, and Platelet endothelial cell adhesion molecule 1 (PECAM-1), a pro-inflammatory adhesion molecule (102) . Also, this study revealed an upregulation of the inflammatory proteins, Intercellular adhesion molecule-1 (ICAM-1), and Vascular cell adhesion protein 1 (VCAM-1) in the brain homogenates of mice exposed to e-cigarettes (102) . Platelets from healthy volunteers exposed to e-cigarettes aerosol show an increase in the expression of globular complement protein C1q receptor (gC1qR) and calreticulin cC1q receptor (cC1qR), two proteins that are associated with the atherosclerotic events, platelet activation and aggregation. In a randomized crossover trial, 25 tobacco smokers were exposed to sham vaping, e-cigarettes without nicotine, and ecigarettes with nicotine. Plasma myeloperoxidase, an enzyme highly expressed in neutrophils and macrophages used as a marker of an inflammatory process (103) , was increased after exposure to e-cigarettes with nicotine, but not in patients exposed to sham vaping or e-cigarettes without nicotine (43) . Other studies have shown increased inflammatory and oxidative stress in non-smokers even when exposed to ecigarettes without nicotine (104) . These data suggest a clear effect of e-cigarettes with nicotine on the production of oxidative stress and inflammation; however, further work is needed to uncover the effects of the non-nicotine e-cigarette contributions to atherosclerosis. High levels of triglycerides and low levels of high-density lipoproteins (HDL) are risk factors for cardiovascular disease (105, 106) . Nicotine promotes loss of body weight and the disturbance of lipoprotein metabolism through the secretion of catecholamines, such as norepinephrine. Catecholamine secretion favors the elevation of LDL and very low density lipoproteins (VLDL) and is also associated with decreased HDL levels (107) (108) (109) . Higher levels of LDL and VLDL are also known risk factors for cardiovascular diseases (110) (111) (112) . A health survey in Korean men showed significantly elevated triglyceride levels in dual users of conventional cigarettes and ecigarettes compared to non-smokers (18) . In addition, there was no significant difference in triglyceride levels between dual users and conventional cigarette-only smokers. However, another work has shown that e-cigarette users have higher triglycerides and lower HDL than never users (79) . HDL cholesterol was significantly lower in both dual users and conventional cigarette only smokers compared to those who never have smoked (18) . E-cigarette vapers had increased levels of LDL and VLDL compared to nonsmokers (113) . Habitual e-cigarette users had increased oxidized LDL levels compared with non-user control individuals (114) . Oxidized LDL can lead to atherosclerosis as it can contribute to the buildup of atherosclerotic plaques (20) . In a gender-specific effect, a plasma lipidome analysis showed that female but not male e-cigarette users had decreased plasmalogens levels (115) . Plasmalogens have a protective role against lipid peroxidation (116) . Clinical trials, animal experiments, and surveys have shown associations between e-cigarette use and negative health outcomes concerning blood lipids and potential cardiovascular diseases; however, more clinical, animal, and epidemiological studies will be needed to establish causation with these negative health outcomes. Adipocyte dysfunction produces systemic inflammation, a pathogenic mechanism underlying the well-known associations between obesity, cardiovascular pathology, hypertension, and metabolic syndrome (117). Thus, adipose tissue, an important regulator of the cardiovascular system (118, 119) , produces bioactive factors that regulate lipid levels and is involved in inflammation, oxidative stress, and insulin resistance (120) . Epidemiological studies have shown that the combination of smoking and obesity results in a higher mortality risk (121) . Additionally, smokers have a subclinical systemic inflammation with decreased adiponectin levels in plasma (122) . The role of the adipose tissue on the effects of smoking in vascular pathology is highlighted by evidence showing that the epicardial adipose tissue and subcutaneous adipose tissue in smokers has higher levels of inflammatory adipokines, namely TNF-α and IL-6 than found in this tissue in non-smokers (123) . In cultured 3T3L1 adipocytes, nicotine-induced AMPactivated protein kinase (AMPK) phosphorylation, lipolysis, and oxidative stress in a concentration-dependent manner (124) . Furthermore, the activation of nAChRs by nicotine stimulated AMPK activation led to the release of free fatty acids (FFAs) from rodent adipocytes (125) (126) (127) (128) . Additionally, systemic administration of nicotine produced lipolysis by inducing the release of catecholamines that bind to β-adrenergic receptors located in adipocytes (129) . In humans, cigarette smoking and obesity have been associated with increased levels of FFAs (130) , which, in turn, are correlated with an increased risk for CVD (131, 132) . FFAs have been broadly studied in their contribution to the induction of metabolic changes that lead to metabolic syndrome (133) and adverse cardiovascular outcomes (134) . Increased FFAs produce a low inflammatory state that is characterized by infiltration and expansion of lymphocytes and macrophages, which produce pro-inflammatory cytokines that interfere with insulin signaling (135) . FFAs are likely one of the key elements in ectopic lipid accumulation, lipotoxicity, mitochondrial dysfunction (136) (137) (138) , and cardiomyopathy (132, 139) . Improvements in wholebody insulin sensitivity can be obtained by pharmacological reduction of chronically elevated plasma FFA levels (140, 141) . Our laboratory has shown that e-cigarettes produce increased plasma levels of FFA and intramyocardial lipid accumulation (39) . Additionally, we have shown that inhibition of lipolysis using acipimox inhibited the hepatic metabolic changes induced by consuming a high-fat diet plus nicotine (142) . Increased FFA promotes inflammation in adipose tissue through the activation of the toll-like receptor 4 (TLR4) signaling (118, 143) . Our team found that e-cigarettes induce a cardiac inflammatory phenotype associated with cardiac dysfunction and atherosclerosis (39) . Associated with this phenotype, we also found increased levels of serum FFA and oxidative stress (39) . Therefore, we postulate that the nicotine present in e-cigarettes increases the levels of FFA and ROS, leading to atherosclerosis and cardiac dysfunction (39) . In a hyperlipidemic, low-density lipoprotein receptor null mouse model, nicotine stimulated macrophages to secrete inflammatory cytokines, creating a pro-inflammatory microenvironment in the sub-endothelium that increased the aortic lesion size by 2.5 times (46). Human monocytes are sensitive to cigarette smoking, NF-κB activation, and the production of pro-inflammatory cytokines such as IL-8 (144) . After infiltration in the arterial wall, monocytes differentiate into macrophages and engulf oxidized low density lipoproteins (LDL) with the help of scavenger receptors creating foam cells, which secrete cytokines that, in turn, recruit more immune cells (145) . In Apolipoprotein E (ApoE) null mice, e-cigarettes induced a cardiac inflammatory phenotype associated with increased serum levels of FFA and atherosclerosis (39) . Together, this evidence suggests that the effects of nicotine and e-cigarettes on FFA, adipokines, and inflammatory cells are potent modulators of cardiovascular physiology. We depict a possible mechanism of these effects in Figure 2 . Aside from the increase of FFA by e-cigarettes, the reported changes in adipose tissue by nicotine warrant further examination of the role of adipocyte tissue on the recruitment and activation of immune cells to the heart and vasculature. Cardiac sympathetic activation is a risk factor for cardiovascular disease (146) , and habitual e-cigarette users have an increased FIGURE 2 | Effects of e-cigarettes on adipocytes and cardiovascular system. In adipocyte tissue, nicotine in e-cigarettes produces the release of FFA and adipokines leading to the activation of macrophages and an inflammatory phenotype that detrimentally affects the cardiovascular system function. activation sympathetic system (114) . Accordingly, e-cigarettes have been reported to produce sympathetic dominance in humans (114) and mouse models (147) . Sympathetic and parasympathetic terminals innervate sinoatrial (SA) and atrioventricular (AV) nodes in the heart. In contrast, arteries and veins only receive sympathetic innervation (148) . nAChRs are the key mediators of synaptic transmission in autonomic ganglia (148) . Nicotine binding to nAChRs led to a release of adrenaline from the adrenal medulla and noradrenaline from postganglionic sympatric nerves, activating the sympathetic nervous system (7, 149) . Blood vessels have α1 and β2 adrenoreceptors, which produce vasoconstriction and vasodilatation, respectively. Since the higher presence of α1 receptor in vessels, high adrenaline concentrations induce vasoconstriction through activation of α1 receptors (148) . β1 adrenergic receptors are expressed in the heart, and their activation leads to increased cardiac contractility and heart rate (148) . The chronic activation of the sympathetic system produces an increased cardiac overload and inflammation, leading to cardiac remodeling (150) . Consistently with the relevance of this mechanism, β-blockers reduce heart failure mortality (151) . Inhaling e-cigarettes (JUUL with nicotine) acutely increased sympathetic neural outflow in young, healthy non-smokers. In contrast, inhalation of a placebo e-cigarette without nicotine elicited no sympathetic dominance (152) . Therefore, the sympathetic dominance produced by e-cigarettes is mainly produced by nicotine. Sympathetic dominance activates the Splenocardiac axis. In this pro-inflammatory axis, the sympathetic stimulation of hematopoietic tissues increases circulating pro-inflammatory monocytes, increasing atherosclerosis and ischemic heart disease (153) . The finding that e-cigarettes activated metabolic activity on spleen and blood vessel walls suggests the activation of the Splenocardiac axis (154) . Sympathetic activity plays a central role in the control of blood pressure. The acute effect of nicotine producing increased blood pressure has been well-researched through independent studies on nicotine and other cigarette studies (155) (156) (157) (158) . Inhalation of nicotine aerosol equivalent to cigarette smoking induces acute high magnitude irregular fluctuations of blood pressure in a pregnant rat model, with the arterial blood pressure being continuously measured (62) . The irregular fluctuations of blood pressure primarily result from nicotineinduced cardiac arrhythmia (62) and probably can not be detected by the intermittent measurement with the conventional Korotkoff method. However, several epidemiological studies have found inconsistent results in comparing blood pressure levels among traditional cigarette smokers and non-smokers (159) . E-cigarettes release nicotine and, after thermal degradation of propylene glycol and glycerin, release aldehydes (160), all of which can potentially cause an acute increase in blood pressure (161) . As mentioned above, nicotine elevates blood pressure through the release of norepinephrine and epinephrine (162) . The effects of aldehydes derived from the use of e-cigarettes are less studied, and the current potential effects and mechanisms are inferred from animal studies directly exposed to aldehydes. In rats, inhaled aerosol of acetaldehydes and propionaldehydes increased blood pressure by activating the sympathetic nervous system through the stimulation of the release of catecholamines (163) . Previous studies have shown that aliphatic aldehydes, besides formaldehyde, had sympathomimetic activity. Aliphatic aldehydes most likely regulate blood pressure by the activation of the sympathetic system found in a study with anesthetized rats described above (163) . More studies are needed to further understand the discrepancy between the effects of different types of aldehydes and the potential acute and chronic effects on blood pressure. A comparison study found similar rates of acute increase in blood pressure when comparing e-cigarette and conventional cigarette use in smokers (164, 165) . E-cigarette devices as the vape pod, JUUL, increased the blood pressure by 6 mm Hg acutely in comparison to nicotine-free e-cigarettes (152) . Nevertheless, the authors have mentioned that the 6 mmHg of increase could be underestimated because the participants were not experienced e-cigarette users, which could be less nicotine absorption (152) . Compared with nonsmokers, conventional cigarettes and e-cigarettes users have a similar pattern of increase in systolic blood pressure, with lesser effects in e-cigarette users (166) . A small double-blinded clinical trial revealed that ecigarettes with nicotine, but not without nicotine increased the peripheral systolic blood pressure and heart rate in humans (167) . Conventional smokers with arterial hypertension that switched to e-cigarettes showed improvements in systolic and diastolic blood pressure (168) . Three other acute comparison studies found that e-cigarette users had decreased blood pressure when compared to conventional cigarette users (169) (170) (171) . Overall, a meta-analysis of the immediate effects of e-cigarettes found that acute use of nicotine e-cigarettes was associated with increased heart rate, systolic blood pressure, diastolic blood pressure (172) . In an acute study, following 45 min of exposure to e-cigarette aerosol, blood pressure levels rose to similar levels of those who smoked tobacco cigarettes for 15 min, suggesting that a longer time is needed for e-cigarette exposure than conventional cigarette exposure on blood pressure (167) . One of the acute studies also used carotidpulse wave velocity to show that an increase of e-cigarette usage from 5 to 30 min increased arterial stiffness to a similar level to that of tobacco smokers (164) . A mouse study indicated little changes in blood pressure among mice that were exposed to filtered air, e-cigarettes, and conventional cigarettes for 8 months (147) . A human study that lasted 3.5 years, found that there was no significant difference in long-term changes in blood pressure when comparing daily e-cigarette users and non-users (173) . Most of the acute comparison studies investigated the temporary increase of blood pressure levels after a short period of e-cigarettes use, most likely due to sympathetic nervous system activation. There are still discrepancies in these acute studies on whether e-cigarette use induced a lower elevation in blood pressure when compared to the use of conventional cigarettes. More data is necessary to fully understand the chronic implications of e-cigarettes use and the potential effects of the ingredients on blood pressure. Platelet adhesion is a common trait of CVD (174) . A whole-body e-cigarette mouse exposure protocol showed that e-cigarettes induce platelet activation with enhanced aggregation (169) . Fine particulate matter also increased platelet adhesion and activation (175) . Exposing mice to e-cigarettes for either 5 or 14 consecutive days increased the activation of platelets as well as shortened thrombosis after exposure to e-cigarettes (176) . Mice with short-term whole-body exposure to e-cigarettes developed a prothrombotic phenotype with hyperactive platelets and higher integrin and phosphatidylserine expression (176) . Ecigarettes increased phosphorylated protein kinase B (Akt) and extracellular signal-regulated kinases (ERK), which are involved in platelet function (176, 177) . Conventional cigarettes and e-cigarettes produced a significant increase in platelet activation in non-smokers (178) . However, there was also a lower increase of platelet aggregation following e-cigarette use than with conventional cigarette use (178) . In a similar study comparing acute effects of conventional cigarette use and e-cigarette use, there was a similar increase in both groups of Nox2, a protein that regulates platelet-activation-associated thrombosis (165) . In vitro studies of platelet exposure to e-cigarette aerosol also found increases in CD40 and P-selectin (175) , which are markers for active platelets and thrombo-inflammation, respectively (161, 179) . In in vivo studies, exposure to e-cigarettes for 5-7 days led to enhanced P-selectin levels after e-cigarette usage (176) . Clinical studies involving tobacco users with controlled conventional cigarette compared to e-cigarette with nicotine use showed acute increases in CD40 and P-selectin markers in conventional cigarette and e-cigarette users (165, 178, 180) . Another study, looking at e-cigarette use with and without nicotine, found a similar increase of CD40 and P-selectin in users of e-cigarettes containing nicotine. In the groups that inhaled aerosol without nicotine, only CD40 increased (181) . In summary, clinical and preclinical studies indicate that ecigarettes consumption increases platelet aggregation, which can have a negative impact by potentiating cardiovascular events. The effects of conventional cigarettes in vascular injury and CVD are well-established (7) . Daily users of e-cigarettes have an increased risk factor for myocardial infarction (182) . This risk appeared similar between e-cigarette and conventional cigarette smokers and was increased in users of both cigarettes and e-cigarettes (dual users) (183) . The Framingham Heart Study showed a strong association between aortic stiffness and a higher incidence of cardiovascular events (184) . Arterial stiffening leads to increased cardiovascular risk, including heart failure, myocardial infarction, and increased mortality. Hemodamicaly, arterial stiffening leads to increased blood pressure, cardiac workload, and decreased myocardial perfusion. Structural components of the arterial wall mainly determine arterial stiffening. Estimation of arterial stiffness is commonly measured by aortic-femoral pulse wave velocity (PWV), that is, the time that it takes for the arterial pulse to propagate from the carotid to the femoral artery. Several studies have shown that ecigarettes increase PWV in humans (43, 164, 185 ). Mice exposed to e-cigarettes for 5 days a week for 8 months showed increased aortic arterial stiffness measured by PWV (147) . To differentiate the vascular effects of nicotine and carriers, a single-blind crossover design study was performed with patients exposed to vaping without nicotine, vaping with nicotine, and sham-vaping. Results from these clinical studies showed that nicotine from e-cigarettes reduced microvessel endothelial function, increased arterial stiffness, and triggered an increase in plasma myeloperoxidase (43) . Nicotine-free e-cigarettes did not change microcirculatory function as well as arterial stiffness and oxidative stress markers (43) . In healthy volunteers, two biomarkers for heightened vascular risk, microvesicles, and endothelial progenitor cells, were increased following exposure to e-cigarettes (180), and these effects were shown to be dependent on nicotine (181) . Ex vivo experiments of wire tension myography and force transduction showed an increased thoracic aortic tension in response to vasoactive-inducing compounds in mice chronically exposed to e-cigarettes (147) . In animal models, mice were exposed for 60 weeks to the e-cigarette with a concentration of nicotine from 0 to 24 mg/mL showed endothelial dysfunction and an increase in endothelial ROS, in addition to a thickening of the vessel wall were dependent on nicotine concentration (186) . Experiments in mice showed that e-cigarettes produced uncoupling of eNOS, and peroxynitrite formation may lead to vascular endothelial dysfunction (187) . Additionally, ROS causes endothelial dysfunction by directly quenching NO (98) . On the other hand, flow-mediated dilation, a marker for the presence of subclinical atherosclerosis, was studied in conventional cigarettes smokers, e-cigarettes smokers, and non-smokers. Conventional cigarette smokers develop impairment of flow-mediated dilation compared to nonsmokers, and electronic cigarette smokers have similar flowmediated dilation as non-smokers. Therefore, this work suggests that the impairment of flow-mediated vasodilation may be nicotine-independent (188) . An article on the beneficial effects of the switch from traditional cigarettes to e-cigarettes showed an early beneficial impact on endothelial function after this switch (189) . The improvement in flow-mediated dilatation was mainly observed in females and non-dual users with little effect in dual users (189) . However, one potential limitation of this study is the lack of a non-smoker control group. Pulse wave analysis (PWA) is a technique commonly used to determine systemic arterial stiffness. The primary outcome derived from PWA is the augmentation index (AIx), which is normalized to the heart rate. Several groups have shown an increase in the AIx after e-cigarette and conventional cigarette use (43, 167, 185) . Chaumont et al. (43) associated these hemodynamic parameters and ROS changes to nicotine without the influence of the non-nicotine components in the e-cigarettes. The two most studied mechanisms for the effect of conventional cigarettes on vasculature are oxidative stress and the promotion of a pro-inflammatory state (7) . In endothelial cells, e-cigarette and conventional cigarette extracts produce DNA damage, ROS generation, and apoptosis; however, cytotoxic effects were blunted by antioxidants (97) , suggesting a pivotal role of ROS. These effects were greater in conventional cigarettes than e-cigarettes (97) . Ecigarette exposure caused endothelial dysfunction through ROS in human endothelial cells derived from induced pluripotent stem cells (iPSC), and their conditioned media induced a pro-inflammatory state in macrophages (190) . These effects were potentiated in cinnamon-flavored products (190) . In human umbilical vein endothelial (HUVEC) cells, ecigarettes produced complement deposition, a phenomenon present in atherosclerotic lesions (191) . This inflammatory phenomenon was related to a reduction of metabolic activity of endothelial cells (191) . Consistently, sections of aortic root stained with Oil Red O from ApoE KO mice exposed to e-cigarettes aerosol, producing blood cotinine levels equivalent to that found in heavy smokers, showed increased development of atherosclerotic lesions (192) . Additionally, e-cigarettes induced an innate immune response associated with aberrant neutrophilic activation in human airway samples (193) . A similar model of e-cigarette induced atherosclerosis showed that damaged mitochondrial DNA in circulating blood may produce the increase of Toll-like receptor 9 (TLR9), leading to increased pro-inflammatory cytokines and macrophages activation (194) . Additionally, pharmacological inhibition of TLR9 can attenuate the ecigarettes exacerbated atherosclerosis in ApoE KO mice (194) . Therefore, growing literature shows evidence for e-cigarette-induced vascular injury. Smoking is a significant predictor of mortality in people with heart failure (118, 195) . The components of e-cigarettes or their heat-produced derivatives have been shown to have an effect on cardiac physiology. For instance, formaldehyde decreased in left ventricle end-systolic pressure and cardiac output (196) , and acetaldehyde produced myocardial mitochondrial damage (197) . Nicotine aerosol inhalation induces acute cardiac arrhythmia where sinoatrial (SA) block, sinus arrest, atrioventricular (A-V) block and supraventricular escape rhythm were demonstrated by ECG analysis in rats suggesting a disturbance of parasympathetic and sympathetic cardiac control mediated by the nAChRs (62) . Mouse models for e-cigarette exposure with pharmacokinetics resembling human e-cigarettes have been developed (192) . In the ApoE KO mice model exposed to 12 weeks of e-cigarettes with cotinine levels similar to the range of heavy smokers, RNAseq analysis revealed dysregulation of inflammatory pathways (39) . Additionally, M-Mode echocardiographic analysis showed a decreased left ventricular fractional shortening (LV%FS), ejection fraction (LVEF), and velocity of circumferential fiber shortening (VCF) in mice exposed to e-cigarettes with nicotine (39) . However, exposure to e-cigarettes without nicotine did not affect cardiac function (39) . Such changes in cardiac function were associated with increased ultrastructural abnormalities indicative of cardiac dysfunction and MDA generation, a marker of oxidative stress but without hypertrophy (39) . These changes were not associated with changes in the gross morphology of the heart. Recently, C57BL/6J mice on an HFD were exposed to e-cigarettes in the presence (2.4% nicotine) or absence (0% nicotine) of nicotine and saline aerosol for 12 weeks (198) . Indeed, we found a decrease in LV%FS, LVEF, and VCF coupled with ultrastructural abnormalities indicative of cardiomyopathy in mice treated with e-cigarette (2.4% nicotine) compared to ecigarette (0% nicotine) or saline exposed mice (198) . Therefore, nicotine seems to be necessary for the induction of systolic dysfunction induced by e-cigarettes in this mouse model (39) . More extended exposure to e-cigarettes of 60 weeks, led to the development of cardiac left ventricular hypertrophy with an increased systemic vascular resistance (186) . Accordingly, another study showed that mice exposed to e-cigarettes for 3 months had increased systolic blood pressure and diastolic blood pressure, associated with cardiac and renal fibrosis and a systemic inflammatory state (199) . Recently, a similar phenotype produced by e-cigarettes in rats showed fibrosis, inflammation, and oxidative stress, but with cardiac hypertrophy (99) . A meta-analysis of cardiovascular outcomes of smokers switching from traditional cigarettes to e-cigarettes did not show any improvement in stroke, myocardial infarction, or coronary heart disease outcomes (200) . However, this work showed a reduction in adverse respiratory effects in smokers who switched to e-cigarettes (200) . Additionally, larger studies have shown that the smokers who do not halt smoking often continue using both conventional cigarettes and e-cigarettes (dual users) (18) . Compared with those who only smoke conventional cigarettes, dual users have a higher cardiovascular risk (201) . The tobacco industry's most recent development is a product deemed as a heat-not-burn (HnB) tobacco cigarettes (202, 203) . These products claim to "heat" tobacco (rolled cast leaf sheets of tobacco soaked in propylene glycol) to temperatures around 350 Celsius rather than burn it at roughly 600 • C. This creates an aerosol that contains nicotine which can be inhaled by users and is promoted to be less toxic and harmful than e-cigarette aerosol or smoke from combusted cigarettes (204) . Phillip Morris International (PMI) is spearheading this new "technology." Their new product (I-Quit-Ordinary-Smoking (IQOS) is being marketed to 1 day replace conventional cigarettes (205) . Before this product gains traction, studies on its acute and long-term CVD safety are urgently needed. Although the public endorses the perception that e-cigarettes are safe (206) , their long-term effects on human health will take a long time to be fully elucidated. In the last several years, e-cigarettes have been progressively regulated. The tobacco prevention act gave authority to the Food and Drug Administration (FDA) to regulate the production, distribution, and marketing of e-cigarettes. The evolving nature of the presented data in this work calls for more regulation, which would include additional safety testing for new flavors and devices that continue to emerge. Studies comparing the CVD effect of e-cigarettes vs. conventional cigarettes and especially those who use e-cigarettes to attempt to quit conventional cigarettes are urgently needed. The past several years have been important in establishing the effects of e-cigarettes on CVD. Although the reduction of conventional cigarettes harm by substituting them with ecigarettes remains under discussion, the molecular mechanism of e-cigarette effects in the cardiovascular system clearly is emerging. The proposed mechanisms for the effects of ecigarettes on CVD are shared with common diseases that affect the general population. Mechanisms such as oxidative stress, inflammation, lipid accumulation, and sympathetic dominance are commonly present in non-smoking patients with atherosclerosis and diabetic cardiomyopathy (207) . This leads to increased concern for people with metabolic or cardiovascular comorbidities that use e-cigarettes. Therefore, these shared mechanisms call for future studies investigating the impact of e-cigarettes on the cardiovascular disease on susceptible populations or representative animal models of these conditions. Additionally, the variety of flavors and delivery systems that change in different vendors will need to be studied. Future discussions in the field may be informed by the different effects of nicotine on the variety of nAChRs and target organs. Nicotine has a dichotomic role as the main substance in harm-reduction products and a harmful substance for the CVS. Therefore, the solution for stopping the deleterious effects of smoking is nicotine cessation and not shifting the source of nicotine delivery. Alternatively, e-cigarettes may be an imperfect, comparatively safer alternative to conventional cigarettes that could be used as a cessation tool; however, the efficiency of this intervention is still uncertain. As a requirement for a specific e-cigarette to be designed as safer than conventional cigarettes, they need to be compared to conventional cigarettes. E-cigarette devices and e-liquids keep changing, and the safety information obtained today may not be valid in a few years. Likely, the scientific discussion that started centuries ago about smoking and health for Dr. Monardes (2) is certain to continue with e-cigarettes. We hope that consensus will come in a shorter time than the one established for conventional cigarettes. History of tobacco and health De Simplicibus Medicamentis ex Occidentali India Delatis The Story of How Tobacco Seduced the World Research on smoking and lung cancer: a landmark in the history of chronic disease epidemiology Surveillance for selected tobacco-use behaviors-United States, 1900-1994 Current Cigarette Smoking Among Adults in the United States How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General A review of current knowledge on Pollution, Cigarette Smoking and COVID-19 diffusion and their relationship with inflammation A Non-Smokable Electronic Spray Cigarette (CA 2518174) (Patent Notice). Canada: Canadian Patent Office Record Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users Pod-mod vs. conventional e-cigarettes: nicotine chemistry, pH, and health effects Last word on viewpoint: pH Buffer capacity and pharmacokinetics: two remaining questions Adolescents' Use of "Pod Mod" E-cigarettes -urgent concerns Trajectories of E-cigarette and conventional cigarette use among youth Prevalence of electronic cigarette dependence among youth and its association with future use Tobacco product use among middle and high school students -United States Dual use of electronic and conventional cigarettes is associated with higher cardiovascular risk factors in Korean men Role of smoking in global and regional cardiovascular mortality The biology behind the atherothrombotic effects of cigarette smoke 21st-century hazards of smoking and benefits of cessation in the United States Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure Air pollution ultrafine particles: toxicity beyond the lung Effects of electronic cigarettes on indoor air quality and health Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns Hidden formaldehyde in e-cigarette aerosols Aldehyde detection in electronic cigarette aerosols Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I Short-term e-cigarette vapour exposure causes vascular oxidative stress and dysfunction: evidence for a close connection to brain damage and a key role of the phagocytic NADPH oxidase (NOX-2) Exposure to acrolein by inhalation causes platelet activation Acrolein exposure from electronic cigarettes Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation Flavorings in tobacco products induce endothelial cell dysfunction In vitro and in vivo cardiac toxicity of flavored electronic nicotine delivery systems Electronic cigarettes: product characterisation and design considerations Chronic intermittent electronic cigarette exposure induces cardiac dysfunction and atherosclerosis in apolipoprotein-E knockout mice Hepatic DNA damage induced by electronic cigarette exposure is associated with the modulation of NAD+/PARP1/SIRT1 axis Ecigarettes and Western diet: important metabolic risk factors for hepatic diseases Connection of nicotine to diet-induced obesity and non-alcoholic fatty liver disease: cellular and mechanistic insights. Front Endocrinol (Lausanne) Differential effects of E-cigarette on microvascular endothelial function Chronic nicotine exposure enhances insulin-induced mitogenic signaling via up-regulation of α7 nicotinic receptors in isolated rat aortic smooth muscle cells A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine α7 Nicotinic acetylcholine receptor mediates right ventricular fibrosis and diastolic dysfunction in pulmonary hypertension Ammonia and other chemical base tobacco additives and cigarette nicotine delivery: issues and research needs Bringing attention to e-cigarette pH as an important element for research and regulation Characteristics and toxicant emissions of JUUL electronic cigarettes Nicotine binding to brain receptors requires a strong cation-pi interaction Inhaled nicotine equivalent to cigarette smoking disrupts systemic and uterine hemodynamics and induces cardiac arrhythmia in pregnant rats The insulin resistance syndrome in smokers is related to smoking habits Insulin resistance and cigarette smoking Weight gain and insulin resistance during nicotine replacement therapy Smoking induces insulin resistance-a potential link with the insulin resistance syndrome dyslipidaemia and exaggerated adrenal androgen response to adrenocorticotropin in male smokers Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes Smoking is independently associated with high plasma insulin levels in nondiabetic men Cigarette smoking and insulin resistance in patients with noninsulindependent diabetes mellitus Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus Cigarette smoking, oral moist snuff use and glucose intolerance Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors Low triglycerides-high highdensity lipoprotein cholesterol and risk of ischemic heart disease Lipid profiles in users of combustible and electronic cigarettes Smoking and incidence of diabetes among U.S. adults: findings from the Insulin Resistance Atherosclerosis Study Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis Smoking and type 2 diabetes: underrecognized risks and disease burden The relationship between insulin resistance and dyslipidaemia in cigarette smokers Insulin resistance as a predictor of age-related diseases Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis Oxidative stress and heart failure Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential Oxidative stress in atherosclerosis Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy Mitochondrial oxidative stress in aging and healthspan The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults Mitochondrial DNA, mitochondrial dysfunction, and cardiac manifestations Mitochondrial dysfunction in cardiac aging E-cigarette aerosol exposure induces reactive oxygen species, DNA damage, and cell death in vascular endothelial cells Oxygen radical-mediated reduction in basal and agonist-evoked NO release in isolated rat heart Comparison of the cardiac effects of electronic cigarette aerosol exposure with waterpipe and combustible cigarette smoke exposure in rats Unveiling the role of inflammation and oxidative stress on age-related cardiovascular diseases Offsetting the impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: is Metformin a viable countermeasure? Myeloperoxidase as an active disease biomarker: recent biochemical and pathological perspectives Acute exposure to e-cigarettes causes inflammation and pulmonary endothelial oxidative stress in nonsmoking, healthy young subjects Hypertriglyceridemia as a cardiovascular risk factor Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: enhancement of hyperlipidemia and depression of high-density lipoprotein Smoking and smoking cessation-The relationship between cardiovascular disease and lipoprotein metabolism: a review The role of norepinephrine and insulin resistance in an early stage of hypertension Oxidized LDL induces vimentin secretion by macrophages and contributes to atherosclerotic inflammation Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Trends of lipophilic, antioxidant and hematological parameters associated with conventional and electronic smoking habits in middle-age romanians Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk Changes in lipid composition associated with electronic cigarette use The protective role of plasmalogens in iron-induced lipid peroxidation Cigarette smoking and adipose tissue: the emerging role in progression of atherosclerosis The role of adipose tissue in cardiovascular health and disease Adipokines: molecular links between obesity and atheroslcerosis The combined relations of adiposity and smoking on mortality Influence of smoking and body weight on adipokines in middle aged women Tobacco smoking and cytokine levels in human epicardial adipose tissue: impact of smoking cessation Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: a role for oxidant stress Activation of AMPKalpha2 in adipocytes is essential for nicotine-induced insulin resistance in vivo Alterations of lipolysis and lipoprotein lipase in chronically nicotine-treated rats Some aspects of the effect of nicotine on plasma FFA and tissue triglycerides Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors Lipid effects of smoking Ageing, adipose tissue, fatty acids and inflammation Metabolic remodeling in diabetic cardiomyopathy A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes Plasma-free fatty acids, fatty acid-binding protein 4, and mortality in older adults (from the Cardiovascular Health Study) The immune cells in adipose tissue Mitochondrial disease and endocrine dysfunction Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance Obesity, insulin resistance and free fatty acids Role of insulin resistance and lipotoxicity in nonalcoholic steatohepatitis Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice TLR4 links innate immunity and fatty acid-induced insulin resistance Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages Monocyte recruitment and foam cell formation in atherosclerosis Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications Chronic exposure to electronic cigarettes results in impaired cardiovascular function in mice Autonomic and endocrine control of cardiovascular function Nicotine and sympathetic neurotransmission Autonomic imbalance and immune activation in chronic heart failure -pathophysiological links Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors Acute effects of electronic cigarettes on arterial pressure and peripheral sympathetic activity in young nonsmokers Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded "cardiovascular continuum Activation of the "Splenocardiac Axis" by electronic and tobacco cigarettes in otherwise healthy young adults Smoking and mechanisms of cardiovascular control The acute effects of smoking on heartrate and blood-pressure -an ambulatory study Effects of fetal and neonatal exposure to nicotine on blood pressure and perivascular adipose tissue function in adult life Acute effects of passive smoking on blood pressure and heart rate in healthy females Smoking and blood pressure phenotypes: new perspective for an old problem Determining the impact of flavored e-liquids on aldehyde production during Vaping The signaling role of CD40 ligand in platelet biology and in platelet component transfusion Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking Effects of inhaled acetaldehyde and propionaldehyde on blood pressure and heart rate Electronic cigarette smoking increases aortic stiffness and blood pressure in young smokers Acute effects of heat-not-burn, electronic vaping, and traditional tobacco combustion cigarettes: the Sapienza University of Rome-vascular assessment of proatherosclerotic effects of smoking (SUR -VAPES) 2 randomized trial Twenty-four-hour cardiovascular effects of electronic cigarettes compared with cigarette smoking in dual users E-cigarettes and cigarettes worsen peripheral and central hemodynamics as well as arterial stiffness: a randomized, double-blinded pilot study Blood pressure control in smokers with arterial hypertension who switched to electronic cigarettes Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes Measurement of cardiovascular and pulmonary function endpoints and other physiological effects following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers Immediate physiological effects of acute electronic cigarette use in humans: a systematic review and meta-analysis Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked. Sci Rep Molecular imaging of platelet-endothelial interactions and endothelial von willebrand factor in early and mid-stage atherosclerosis Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations Short-term E-cigarette exposure increases the risk of thrombogenesis and enhances platelet function in mice Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2 Impact of tobacco versus electronic cigarette smoking on platelet function Pselectin ligation induces platelet activation and enhances microaggregate and thrombus formation Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers Electronic cigarettes containing nicotine increase endothelial and platelet derived extracellular vesicles in healthy volunteers Association between electronic cigarette use and myocardial infarction electronic cigarette use and myocardial infarction among adults in the US population assessment of tobacco and health Microvascular function contributes to the relation between aortic stiffness and cardiovascular events: the Framingham Heart Study Electronic cigarette smoking increases arterial stiffness and oxidative stress to a lesser extent than a single conventional cigarette: an acute and chronic study Long-term electronic cigarette exposure induces cardiovascular dysfunction similar to tobacco cigarettes: role of nicotine and exposure duration Electronic cigarette exposure causes vascular endothelial dysfunction due to NADPH oxidase activation and eNOS uncoupling Differential effects of tobacco cigarettes and electronic cigarettes on endothelial function in healthy young people Cardiovascular effects of switching from tobacco cigarettes to electronic cigarettes Modeling cardiovascular risks of E-cigarettes with human-induced pluripotent stem cell-derived endothelial cells Endothelial cell inflammatory reactions are altered in the presence of ecigarette extracts of variable nicotine A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers E-cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion Electronic cigarettes induce mitochondrial DNA damage and trigger TLR9 (toll-like receptor 9)-mediated atherosclerosis Predictors of two-year mortality in Asian patients with heart failure and preserved ejection fraction Effects of formaldehyde on cardiovascular system in in situ rat hearts Effects of acetaldehyde and L-carnitine on morphology and enzyme activity of myocardial mitochondria in rats Electronic cigarettes cause alteration in cardiac structure and function in diet-induced obese mice Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice How effective are electronic cigarettes for reducing respiratory and cardiovascular risk in smokers? A systematic review Association between E-cigarette use and cardiovascular disease among never and current combustible-cigarette smokers Evaluation of the tobacco heating system 2.2. Part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol A New ingenious enemy: heat-notburn products. tobacco use insights IQOS: examination of Philip Morris International's claim of reduced exposure Invisible smoke: third-party endorsement and the resurrection of heat-not-burn tobacco products Adolescent's health perceptions of e-cigarettes: a systematic review Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.Copyright © 2022 Espinoza-Derout, Shao, Lao, Hasan, Rivera, Jordan, Echeverria, Roos, Sinha-Hikim and Friedman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.